CDY 1.43% 7.1¢ cellmid limited

2018 - The Year of the BioTechs, page-616

  1. 1,165 Posts.
    lightbulb Created with Sketch. 27
    Given current price action the market is not anticipating a meaningful increase in revenue.

    The conditions are ripe for a breakout to the upside should the market be surprised by strong 4Q results.
 
watchlist Created with Sketch. Add CDY (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.